Abstract
Abstract: Colorectal liver metastases (CLM) are not always resectable at the time of diagnosis. An insufficient future liver remnant is a factor excluding patients from curative intent resection. To deal with this issue, two-stage hepatectomy was introduced approximately 20 years ago. It is a sequential treatment strategy for bilateral CLM, which consists of preoperative chemotherapy, portal vein embolization, and planned first and second liver resections. This study reviews current evidence supporting use of two-stage hepatectomy.
Original language | English (US) |
---|---|
Pages (from-to) | 594-603 |
Number of pages | 10 |
Journal | Journal of surgical oncology |
Volume | 119 |
Issue number | 5 |
DOIs | |
State | Published - Apr 1 2019 |
Keywords
- colorectal liver metastasis
- future liver remnant
- portal vein embolization
- two-stage hepatectomy
ASJC Scopus subject areas
- Surgery
- Oncology
MD Anderson CCSG core facilities
- Clinical Trials Office